ImmunityBio, Inc.IBRXNASDAQ
Loading
Net Debt Over TimeElevated
Percentile Rank100
3Y CAGR+8.5%
5Y CAGR+26.8%
Studio
Year-over-Year Change

Total debt minus cash and cash equivalents

3Y CAGR
+8.5%/yr
Annual compound
5Y CAGR
+26.8%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.3x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
2025$789.78M+118.9%
2024$360.74M-21.8%
2023$461.27M-25.5%
2022$619.13M+33.3%
2021$464.56M+93.1%
2020$240.63M+36559.4%
2019$-660000.00+93.3%
2018$-9.91M+40.3%
2017$-16.60M-13174.0%
2016$127000.00-